17.03.2016 • News

Solvay to Exit Ineos Chlorvinyls Early

Solvay has announced it will quit the Inovyn chlorvinyls joint venture with Ineos in the second half of 2015, more than two years earlier than anticipated, giving its Swiss-based partner 100% control.

The Belgian chemicals group originally planned to exit the 50:50 partnership in July 2018, three years after forming Inovyn with Ineos in July 2015 after a protracted EU antitrust investigation.

Solvay will receive a final performance-based exit payment of €335 million, which is higher than the maximum of €280 million targeted when final terms of the deal were agreed last July. At that time, the group received €150 million in exchange for its European chlorvinyls business. It also transferred pension and environmental liabilities with an estimated value of €260 million.

Jean-Pierre Clamadieu, Solvay’s CEO, said the early exit was due to a fast and efficient integration that had turned Inovyn into a “sound and sustainable chlorvinyls player.” This, he said, “allows us to bring forward Solvay’s exit and to further focus on its portfolio transformation, while achieving a first step in de-leveraging the balance sheet.”

Ineos chairman Jim Ratcliffe added: “Chlorvinyls businesses are core to large petrochemicals companies such as ours and through this planned acquisition Inovyn will have an owner with a long-term vision that provides stability for its business and employees.”

Closure of the transaction is subject to finalizing legal agreements and the usual regulatory approvals.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.